Catalyst Pharmaceuticals, Inc (CPRX) insider trading
Every open-market stock purchase and sale by Catalyst Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Company insiders sold $1.8M over the last 12 months (3 sales), with no open-market buys.
- Last company insider buy: Patrick J McEnany (CEO), $44.5K, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.8M (3 sales). Last close $31.49 on Jul 14, 2026.
Recent CPRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 15, 2026 | Patrick J McEnany (Director) | Sold (not open market) | $131M |
| Jul 15, 2026 | Steve Miller (Officer) | Sold (not open market) | $34.5M |
| Jul 15, 2026 | Donald A Denkhaus (Director) | Sold (not open market) | $15.7M |
| Jul 15, 2026 | David S Tierney (Director) | Sold (not open market) | $12.1M |
| Jul 15, 2026 | Richard J Daly (CEO) | Sold (not open market) | $8.5M |
| Jul 15, 2026 | Brian Elsbernd (C-suite exec) | Sold (not open market) | $7.6M |
| Jul 15, 2026 | Preethi Sundaram (C-suite exec) | Sold (not open market) | $1.7M |
| Jul 15, 2026 | Jeffrey Del Carmen (C-suite exec) | Sold (not open market) | $452K |
| Jul 15, 2026 | Michael Wayne Kalb (CFO) | Sold (not open market) | $430K |
| Jul 15, 2026 | Tamar Thompson (Director) | Sold (not open market) | $119K |
| Jul 15, 2026 | Molly Harper (Director) | Sold (not open market) | $116K |
| Jul 15, 2026 | William T. Andrews (C-suite exec) | Sold (not open market) | $72.7K |
| Jul 15, 2026 | Gregg Russo (C-suite exec) | Sold (not open market) | $15K |
| Jul 15, 2026 | Daniel J. Curran (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Patrick J McEnany (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Richard J Daly (CEO) | Sold (not open market) | — |
| Jul 15, 2026 | David S Tierney (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Molly Harper (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Tamar Thompson (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Michael Wayne Kalb (CFO) | Sold (not open market) | — |
| Jul 15, 2026 | Jeffrey Del Carmen (C-suite exec) | Sold (not open market) | — |
| Jul 15, 2026 | Richard J Daly (CEO) | Sold (not open market) | — |
| Jul 15, 2026 | David S Tierney (Director) | Sold (not open market) | — |
| Jul 15, 2026 | Preethi Sundaram (C-suite exec) | Sold (not open market) | — |
| Jul 15, 2026 | Richard J Daly (CEO) | Sold (not open market) | — |
Who's trading CPRX
- William T. Andrews, C-suite exec: other filings, last Jul 15, 2026
- Daniel J. Curran, Director: other filings, last Jul 15, 2026
- Donald A Denkhaus, Director: other filings, last Jul 15, 2026
- Richard J Daly, CEO: other filings, last Jul 15, 2026
- Jeffrey Del Carmen, C-suite exec: sold $256K (1 sale), last Jul 15, 2026
- Brian Elsbernd, Officer: sold $908K (1 sale), last Jul 15, 2026
- Preethi Sundaram, C-suite exec: other filings, last Jul 15, 2026
- Tamar Thompson, Director: other filings, last Jul 15, 2026
- David S Tierney, Director: other filings, last Jul 15, 2026
- Molly Harper, Director: sold $622K (3 sales), last Jul 15, 2026
- Michael Wayne Kalb, CFO: other filings, last Jul 15, 2026
- Patrick J McEnany, Director: other filings, last Jul 15, 2026
- Steve Miller, Officer: other filings, last Jul 15, 2026
- Gregg Russo, C-suite exec: other filings, last Jul 15, 2026
Get free alerts when an insider at Catalyst Pharmaceuticals, Inc files a new trade →